Physician Perceptions of Dose Escalation for Type 2 Diabetes Medications in the United States.

Kristina S BoyeJessica B JordanRaleigh MalikLouis S Matza

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)

Although common with T2D treatments, escalating the dose of T2D medication was not perceived by physicians to be a significant barrier to attaining treatment goals or prescribing medication. Multiple factors contribute to the decision to escalate the dose of T2D medication.

Keyphrases

primary care
healthcare
type diabetes
adverse drug
emergency department
mental health
depressive symptoms
physical activity
cardiovascular disease
randomized controlled trial
social support
clinical trial
glycemic control
decision making
adipose tissue
study protocol
replacement therapy
weight loss
drug induced